Author

N. Dyson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Ahluwalia· 1 shared A. Dall'Agnese· 1 shared A. Farago· 1 shared A. Font-Tello· 1 shared A. Shabbir· 1 shared A. Tewari· 1 shared B. Drapkin· 1 shared C. Borghi· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Ahluwalia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: a novel mechanism to promote redox health?

G. MASSIMO, R. S. Khambata, T. Chapman, K. Birchall, A. Shabbir, N. Dyson, K. Rathod, C. Borghi, A. Ahluwalia

This study examines how natural mutations in human XDH affect XOR activity, revealing varied impacts on UA, ROS, and NO production, and suggests potential therapeutic strategies for cardiovascular disease.

bioRxiv · Mar 24, 2023 · PreprintBiochemistry

Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer

P. Cejas, Y. Xie, A. Font-Tello, K. Lim, S. Symala, X. Qiu, A. Tewari, N. Shah, H. Nguyen, R. Patel, L. Brown, I. Coleman, W. M. Hackeng, L. Brosens, K. Dreijerink, , H. W. Long

This study identifies two distinct subtypes of neuroendocrine prostate cancer based on neuronal transcription factors and highlights their epigenetic convergence and therapeutic implications.

bioRxiv · Sep 13, 2020Cancer Biology